Skip to Content
Discovering the causes of cancer and the means of prevention

Publications Search - Abstract View

Title: Natural Acquired Immunity Against Subsequent Genital Human Papillomavirus Infection: A Systematic Review and Meta-analysis.
Authors: Beachler DC,  Jenkins G,  Safaeian M,  Kreimer AR,  Wentzensen N
Journal: J Infect Dis
Date: 2016 May 1
Branches: CGB, IIB
PubMed ID: 26690341
PMC ID: PMC4813740
Abstract: BACKGROUND: Studies have been mixed on whether naturally acquired human papillomavirus (HPV) antibodies may protect against subsequent HPV infection. We performed a systematic review and meta-analysis to assess whether naturally acquired HPV antibodies protect against subsequent genital HPV infection (ie, natural immunity). METHODS: We searched the MEDLINE and EMBASE databases for studies examining natural HPV immunity against subsequent genital type-specific HPV infection in female and male subjects. We used random-effects models to derive pooled relative risk (RR) estimates for each HPV type. RESULTS: We identified 14 eligible studies that included >24 000 individuals from 18 countries that examined HPV natural immunity. We observed significant protection against subsequent infection in female subjects with HPV-16 (pooled RR, 0.65; 95% confidence interval, .50-.80) and HPV-18 (0.70; .43-.98) but not in male subjects (HPV-16: 1.22; .67-1.77 [P= .05 (test for heterogeneity)]; HPV-18: 1.50; .46-2.55; [P= .15]). We also observed type-specific protection against subsequent infection for a combined measure of HPV-6/11/31/33/35/45/52/58 in female subjects (pooled RR, 0.75; 95% confidence interval, .57-.92). Natural immunity was also evident in female subjects when analyses were restricted to studies that used neutralizing assays, used HPV persistence as an outcome, or reported adjusted analyses (eachP< .05). CONCLUSIONS: HPV antibodies acquired through natural infection provide modest protection against subsequent cervical HPV infection in female subjects.